胸部肿瘤放疗后心血管相关死亡风险的空间分布与预测模型
该研究分析2000至2020年接受放疗的胸部肿瘤患者,评估心血管相关死亡(CVRD)风险。结果显示放疗患者CVRD风险显著高于一般人群(总体AER=28.59,SMR=2.37,95%CI:2.33-2.40),右胸风险低于左胸(HR=0.84,95%CI:0.79-0.89),左肺下叶风险高于上叶(HR=1.11,95%CI:1.01-1.22),并构建左肺下叶放疗后CVRD风险预测模型(C-index=0.67,95%CI:0.67-0.68)。
要点
- 胸部放疗患者CVRD风险显著高于一般人群,SMR=2.37。
- 右胸放疗CVRD风险显著低于左胸,HR=0.84。
- 左肺下叶放疗CVRD风险显著高于上叶,HR=1.11。
核心结论
- 胸部放疗显著增加心血管疾病风险,左肺下叶肿瘤患者CVRD风险最高。
- 研究首次系统评估放疗后CVRD风险的空间分布,识别左肺下叶为最高风险区域。
- 构建的预测模型有助于胸部恶性肿瘤CVRD风险的个体化管理与预测。
研究设计与样本
- 分析2000至2020年接受放疗的胸部肿瘤患者数据。
- 采用死亡率、Fine-Gray竞争风险模型、标准化死亡比(SMR)、绝对超额风险(AER)和Cox回归评估CVRD风险并开发预测模型。
主要发现
- 放疗患者CVRD风险显著高于一般人群:总体AER=28.59,SMR=2.37(95%CI:2.33-2.40)。
- 右胸放疗CVRD风险显著低于左胸:HR=0.84(95%CI:0.79-0.89)。
- 左肺下叶放疗CVRD风险显著高于上叶:HR=1.11(95%CI:1.01-1.22)。
- 左肺下叶放疗后CVRD风险预测模型C-index=0.67(95%CI:0.67-0.68)。
临床怎么用
- 胸部肿瘤放疗时应关注心血管相关死亡风险,尤其左肺下叶肿瘤患者。
- 可参考空间分布特征优化放疗计划,以降低CVRD风险。
- 预测模型可用于个体化风险评估和长期随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiotoxicity following thoracic radiotherapy remains a critical issue, and this study aimed to assess the risk of Cardiovascular-Related Death (CVRD) after thoracic radiotherapy while comparing the risk of CVRD at different cancer sites. Data on patients with thoracic cancers treated with radiotherapy between 2000 and 2020 were analyzed, and the risk of CVRD was evaluated using death rates, Fine-Gray competing risks model, standardized mortality ratio (SMR), absolute excess risk (AER), and Cox regression to develop a predictive model. Patients receiving radiotherapy for thoracic cancer had a significantly increased risk of CVRD compared with the general population (Overall AER = 28.59, SMR = 2.37, 95% CI: 2.33-2.40). The risk of CVRD after radiotherapy was significantly lower in the right chest than the left (HR = 0.84, 95% CI: 0.79-0.89) and significantly higher in the left lower lung than in the upper (HR = 1.11, 95% CI: 1.01-1.22). A predictive model for the risk of CVRD in patients with left lower lung after radiotherapy was further constructed (C-index = 0.67, 95% CI: 0.67-0.68). The findings highlight that thoracic radiotherapy significantly increases cardiovascular disease risk, with patients with left lower lung cancer exhibiting the highest CVRD risk. A robust predictive model was developed, offering valuable insights for managing and predicting CVRD risk in thoracic malignancies. This study is the first to systematically assess spatial CVRD risk distribution post-radiotherapy, identifying the left lower lung as the highest-risk region. The predictive model enhances personalized risk management, improving long-term outcomes for thoracic cancer patients.
引用
- Zhang Z, Yao D, Jiang R, et al. Risk of cardiovascular-related death after radiotherapy for thoracic cancer. Radiat Oncol. 2025. PMID: 41366796. doi:10.1186/s13014-025-02770-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。